Apellis Pharmaceuticals, Inc. APLS
41.03 USD 0.00 (+0.00%)
At closeMay 15, 2026, 4:00 PM EDT
41.06 +0.03 +0.07%
After hours · May 15, 4:00 PM ET
41.03 Day range 41.05
52-week range unavailable
- YTD
- +63.34%
- 1 year
- +150.79%
APLS revenue history
Revenue is income from the company’s ordinary business activities.
1,003,782,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 1,003,782,000 | 222,415,000 | 28.46% |
| FY 2024 | 2024-12-31 | 781,367,000 | 384,776,000 | 97.02% |
| FY 2023 | 2023-12-31 | 396,591,000 | 321,169,000 | 425.83% |
| FY 2022 | 2022-12-31 | 75,422,000 | 8,859,000 | 13.31% |
| FY 2021 | 2021-12-31 | 66,563,000 | -184,083,000 | -73.44% |
| FY 2020 | 2020-12-31 | 250,646,000 | 250,646,000 | Not meaningful |
| FY 2019 | 2019-12-31 | 0 | 0 | Not meaningful |
| FY 2018 | 2018-12-31 | 0 | 0 | Not meaningful |
| FY 2017 | 2017-12-31 | 0 | 0 | Not meaningful |
| FY 2016 | 2016-12-31 | 0 | 0 | Not meaningful |
| FY 2015 | 2015-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-05-08T14:23:51.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.